SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-002318
Filing Date
2022-01-25
Accepted
2022-01-25 16:00:38
Documents
12
Period of Report
2022-01-25
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K onct-8k_20220125.htm   iXBRL 8-K 34945
  Complete submission text file 0001564590-22-002318.txt   163695

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA onct-20220125.xsd EX-101.SCH 5697
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20220125_lab.xml EX-101.LAB 19424
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20220125_pre.xml EX-101.PRE 11587
6 EXTRACTED XBRL INSTANCE DOCUMENT onct-8k_20220125_htm.xml XML 3566
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 22553911
SIC: 2834 Pharmaceutical Preparations